Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
FDA Commissioner Outlines Age‑stratified COVID‑booster Framework, Calls for Company Trials
Summary
Dr. McCary described an age‑stratified framework for future COVID‑19 boosters that would limit routine boosters for healthy younger people absent new trial data, and said FDA published a framework in the New England Journal of Medicine to provide predictability for developers.
Dr. McCary, the Food and Drug Administration commissioner, told senators that the agency published a framework in the New England Journal of Medicine proposing an age‑stratified approach to future COVID‑19 booster authorizations.
"We've been suspending that role for the last 4 years with COVID boosters," Dr. McCary said, explaining the agency now expects clinical trial data for boosters aimed at younger, healthy…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
